Enhancing filtration rates by the use of blood flow around the capillaries of plasmafilters: An in vitro study

International Journal of Artificial Organs

Volumn 24, Issue 11, 2001, Pages 821-831

  Unger, Juliane K ^a   Janssen, V R ^a   Kashefi, A ^a   Haltern, C ^a   Klosterhalfen, B ^a   Fischer, Y ^a   Gressner, A M ^a   Rossaint, R ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Acute liver failure; Clearance rate; In vitro; Multiorgan failure; Plasmaseparation; Sepsis

Indexed keywords

BLOOD; BLOOD VESSELS; INVERSE PROBLEMS; MICROCIRCULATION; PATIENT TREATMENT;

ACUTE LIVER FAILURE; BLOOD FLOW; CLEARANCE RATES; FILTRATION RATES; FLOWTHROUGH; IN-VITRO; MULTIORGAN FAILURE; PLASMASEPARATION; SEPSIS; VITRO STUDIES;

CAPILLARITY;

ANIMAL CELL; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD; BLOOD CLOTTING PARAMETERS; BLOOD COMPATIBILITY; BLOOD FILTER; BLOOD FILTRATION; CAPILLARY FLOW; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENTAL MODEL; FILTER DESIGN; HEMOLYSIS; HEPARINIZATION; IN VITRO STUDY; LIVER FAILURE; MULTIPLE ORGAN FAILURE; NONHUMAN; PLASMA; PLASMAPHERESIS; SEPSIS; SWINE; THROMBOCYTE COUNT;

EID: 0035717258     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880102401111     Document Type: Article

References (21)

1. Plasmafiltration in Sepsis Group: Continuous plasmafiltration in sepsis syndrome
2. Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome
3. Plasmapheresis in the critically ill patient
4. Plasmapheresis in the treatment of primary septic shock in humans
5. Plasmapheresis in acute liver failure
6. Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion
7. Effect of plasma exchange on serum tissue inhibitor metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis
8. Hepatic blood flow and splanchnic consumption in patients with liver failure. Effect of high volume plasmapheresis
9. Continuous removal of middle molecules by hemofiltration in patients with acute liver failure
10. Indication for hybrid liver support
11. Hepatocyte liver-assist systems - A clinical update
12. Extracorporeal liver assist devices in acute liver failure
13. Acute liver failure: Targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure
14. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure
15. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial
16. Swine in clinical chemistry
17. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver
18. Dialysis against a recycled albumin solution enables the removal of albumin bound toxins
19. Microdomain structure of polymeric surfaces - Potential for improving blood treatment procedures
20. Plasmafiltration in sepsis: Removing the evil humors
21. Endothelin-1 in patients with fulminant hepatic failure: Influence of high-volume plasmapheresis